-
A randomised controlled trial presented at the ERS Congress 2025 suggests robotic-assisted bronchoscopy (RAB) combined with...
-
Pleural effusion sediment is commonly used to detect oncogenic mutations in lung carcinoma, but its sensitivity...
-
Remote monitoring increases symptom control and reduces hospitalisations in children with asthma, according to research presented...
-
A randomised controlled trial (RCT) presented at the European Respiratory Society (ERS) Congress in September suggests...
-
Late last year, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) released its 2026 Global...
-
Pneumonia. At the end of 2025, the American Thoracic Society (ATS) published new guidance on the...
-
In December, the European Society for Medical Oncology (ESMO) published a new clinical practice guideline for...
-
BTK. Also presented at the ASH Annual Meeting were the results from the first randomised phase...
-
Highlights from the 67th ASH Annual Meeting: Azacitidine+venetoclax outperforms standard care in AML
Patients newly diagnosed with acute myeloid leukaemia (AML) who are eligible for intensive chemotherapy fare significantly...
-
First results from the phase 3 GIMEMA ALL2820 trial suggest chemotherapy-free combination treatment outperforms a combination...
-
In November 2025, the US Food and Drug Administration (FDA) approved epcoritamab with rituximab and lenalidomide...
-
Stereotactic body radiotherapy (SBRT) is an established treatment for previously unirradiated spinal metastases, however...
ADVERTISEMENT
ADVERTISEMENT